Amir Reichman
Vorstandsvorsitzender bei SCINAI IMMUNOTHERAPEUTICS LTD.
Vermögen: 90 048 $ am 31.05.2024
Aktive Positionen von Amir Reichman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Direktor/Vorstandsmitglied | 02.03.2021 | - |
| Vorstandsvorsitzender | 02.03.2021 | - |
Karriereverlauf von Amir Reichman
Ehemalige bekannte Positionen von Amir Reichman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Corporate Officer/Principal | 01.09.2015 | 01.03.2021 |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Corporate Officer/Principal | 01.01.2011 | 01.01.2015 |
| NEURODERM LTD | Gründer | 01.01.2003 | 01.01.2009 |
| Corporate Officer/Principal | 01.01.2003 | 01.01.2009 |
Ausbildung von Amir Reichman
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Ben-Gurion University of the Negev | Undergraduate Degree |
Statistik
International
| Israel | 4 |
| Vereinigte Staaten | 3 |
| Belgien | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) | |
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
- Börse
- Insiders
- Amir Reichman
- Erfahrung
